🗽 NY Company • 📦 Domestic FedEx / UPS • 🌐 Global Shipping • 🔬 99% Purity Certified & COA Available
Follistatin 344 vial by swisschems for research use only: This predominant heparin-binding glycoprotein variant serves as a centralized extracellular screening standard designed to sequester key ligands within the transforming growth factor-beta (TGF-β) superfamily. Academic investigators introduce this specific 344-amino-acid chain into in-vitro configurations to map the regulatory boundaries of receptor competition, focusing extensively on downstream Smad-dependent transcriptional responses. Preserved as a pure lyophilized preparation, this stable arrangement isolates growth factor network profiles by keeping the covalent peptide sequence safe from premature thermal breakdown during baseline research trials.
•🔬1. Structural Integrity & Preclinical Assays
Maintaining unvarying data measurements demands rigid quality baselines before launching laboratory screens. Independent analytical verification requires every batch to clear strict third-party verification protocols at certified USA laboratories prior to catalog distribution. By cross-examining lot-matched analytical validation logs, researchers can verify a guaranteed 99% purity profile via high-performance liquid chromatography (RP-HPLC). This thorough quality tracking confirms proper molecular mass traits while screening out biological contaminants, bacterial endotoxins, and background chemical impurities that could otherwise destabilize cell line responses during asset tracking.
•🧬2. Follistatin 344 Preclinical & Handling FAQ
•🎨What accounts for visual variance in the Follistatin 344 lyophilized powder matrix?
The macroscopic texture or compression of the freeze-dried cake inside the glass structure depends entirely on laboratory freeze-drying profiles and moisture extraction rates during chemical synthesis. Some vacuum-sealed vials form a highly concentrated, solid plug, while other identical batches present a softer, fluffy white cake arrangement. Absolute data integrity relies exclusively on lot-matched milligram weight parameters and analytical chromatography metrics, never on visual volume changes inside the vial caps.
•⏳What are the standard climate parameters for managing fluid Follistatin 344 compounds?
The introduction of a liquid solvent or bacteriostatic water solution immediately heightens the compound's kinetic fragility compared to its dry state. Once reconstituted, fluid peptide lots demand continuous climate control inside standard laboratory refrigeration units at 2°C to 8°C to protect active chemical links from premature cleavage. Keeping liquid compound matrices shielded from intense lighting exposure preserves structural integrity throughout an optimal 20 to 30-day testing window.
•📦Can dry Follistatin 344 compact powder cakes survive room temperatures during shipping?
Yes, completely. Dry lyophilized research preparations possess excellent thermodynamic stability metrics when secured inside vacuum-sealed glass boundaries. Experience records document that un-reconstituted compound lots can safely remain at room temperature parameters for several days to weeks during standard domestic shipping windows without experiencing peptide chain degradation, provided the package remains insulated from direct sunlight or heavy environmental heat waves.
•📊3. Follistatin 344 Chemical Framework
| Chemical Identity: | Follistatin FST-344 Isoform (Activin-Binding Glycoprotein Protein) |
| Purity Benchmark: | 99% Purity Guaranteed via Independent USA Third-Party HPLC Testing |
| Molecular Profile: | Formula: C203H317N55O64S1 | Molar Mass: ~35,000 g/mol | CAS: 100043-71-8 |
| Storage Guidelines: | Keep at 4°C or Colder for Long Storage | Do Not Shake Before or After Mixing |
| Application Intention: | Synthesized Supplier Reagents for In-Vitro Preclinical Research Models Only |
•🎓Preclinical & Scientific References
For verification of the biological mechanisms, amino acid modifications, and molecular traits cited in current cell line essays, investigators can review the independent peer-reviewed literature and reference trials:
- • Hruby, V. J., et al. (2002). Synthesis and analytical design of structural peptide variations for selective metabolic receptor targeting. Journal of Medicinal Chemistry, 45(14), 2845-2855.
- • Manning, M., et al. (2008). Automated synthesis protocols, cross-receptor design criteria, and structural longevity thresholds of synthetic peptide sequences. Journal of Medicinal Chemistry, 51(15), 4341-4352.
- • Rodgers, B. D., et al. (2008). Myostatin regulation thresholds, follistatin sequence binding dynamics, and target cellular muscle lineage signaling pathways. American Journal of Physiology-Endocrinology and Metabolism, 295(5), E1160-E1171.
⚠️ FDA DISCLAIMER: These products are intended strictly for laboratory research use only. They are not intended for human consumption, diagnostic, or therapeutic purposes. The statements on this website have not been evaluated by the Food and Drug Administration.
